Human cysticercosis: Parasitology, pathology, clinical manifestations and available treatment

This publication has 84 references indexed in Scilit:

• High-dose praziquantel for neurocysticercosis: serum and CSF concentrations
  Acta Neurologica Scandinavica, 2009
• Extraneural Cysticercosis Presenting as a Tumor in a Seronegative Patient
  Clinical Infectious Diseases, 1992
• Neurocysticercosis: regression of a fourth ventricular cyst with praziquantel.
  Journal of Neurology, Neurosurgery & Psychiatry, 1991
• High-Dose Praziquantel for Neurocysticercosis: Efficacy and Tolerability
  European Neurology, 1990
• Praziquantel
  Medicinal Research Reviews, 1983
• Treatment of Cysticercosis with Praziquantel in Colombia
  The American Journal of Tropical Medicine and Hygiene, 1982
• Cysticercus of 60-Milliliter Volume in Human Brain *
  The American Journal of Tropical Medicine and Hygiene, 1981
• Absence of mutagenicity of praziquantel, a new, effective, anti-schistosomal drug, in bacteria, yeasts, insects and mammalian cells
  Mutation Research/Genetic Toxicology, 1978
• Metabolism of praziquantel in man
  European Journal of Drug Metabolism and Pharmacokinetics, 1978
• A CASE OF GENERAL INFECTION BY CYSTICERCUS CELLULOSÆ.
  The Lancet, 1921